Oncological and functional results after robot-assisted radical prostatectomy in high-risk prostate cancer patients
Por:
Sanchez-Nunez, Juan E., Gonzalez-Cuenca, Eduardo, Fernandez-Noyola, Gerardo, Gonzalez-Bonilla, Eduardo A., Doria-Lozano, Mario, Rosas-Nava, Jesus E., Corona-Montes, Victor E.
Publicada:
1 jul 2022
Categoría:
Surgery
Resumen:
Background: Pentafecta is currently the standard in the comprehensive
evaluation of patients undergoing radical prostatectomy, the objective
of this study is the evaluation of oncological and functional outcomes
in patients with prostate cancer of high risk undergoing robot-assisted
radical prostatectomy. Method: Descriptive, retrospective study of 20
cases with a diagnosis of high-risk prostate cancer. The high-risk group
is composed of a prostate-specific antigen equal or greater than 20
ng/mL, Gleason score equal or greater than 8, or clinical stages T2/T3
treated with robotic approach. Results: Biochemical control was achieved
from the first six weeks after the surgical event. 75% (n = 15) had
negative surgical margins. 100% of the patients (n = 20) presented
urinary continence immediately after removal of the urinary catheter.
Erectile function was preserved at 3, 6 and 12 months in 100% of the
patients who underwent neuropreservation but with use of an PDE
inhibitor. (n = 5). Complications were reported in 10% (Clavien-Dindo
I-II). Conclusions: Robot-assisted radical prostatectomy in patients
with high-risk prostate cancer is considered an appropriate treatment
option in selected patients. A different experimental design is needed
to define the advantages or disadvantages of this approach, as well as
to determine its role and application in clinical practice.
Filiaciones:
Sanchez-Nunez, Juan E.:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Gonzalez-Cuenca, Eduardo:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Fernandez-Noyola, Gerardo:
División de Urología, Hospital General Dr. Manuel Gea González
Gonzalez-Bonilla, Eduardo A.:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Doria-Lozano, Mario:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Rosas-Nava, Jesus E.:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Servicio de Urología, Hospital Ángeles del Pedregal
Centro de Cirugía Robótica, San Ángel Inn Universidad
Corona-Montes, Victor E.:
Servicio de Urología, Unidad de Uro-Oncología, Hospital General de México Dr. Eduardo Liceaga, Universidad Nacional Autónoma de México
Servicio de Urología, Hospital Ángeles del Pedregal
Servicio de Urología, Centro Médico A.B.C. (American British Cowdray) Observatorio. Ciudad de México, Mexico
gold, Gold
|